Benjamin J. Hindson - 24 Feb 2025 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: President and Chief Scientific Officer, Director
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson
Issuer symbol: TXG
Transactions as of: 24 Feb 2025
Net transactions value: -$50,603
Form type: 4
Filing time: 26 Feb 2025, 17:43:37 UTC
Previous filing: 25 Nov 2024
Next filing: 19 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Sale	$50,603	-4,573	-1.3%	$11.07	335,324	24 Feb 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

President and Chief Scientific Officer